BMB Rep. 2015; 48(5): 243-248  
Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson’s disease and beyond
Jae Ryul Bae1 & Byoung Dae Lee1,2,3,*
1Department of Neuroscience, 2Neurodegeneration Control Research Center, 3Department of Physiology, School of Medicine, Kyung Hee University, Seoul 130-701, Korea
Correspondence to: Tel: +82-2-961-9381; Fax: +82-2-969-4570; E-mail:
Received: February 22, 2015; Published online: May 31, 2015.
© Korean Society for Biochemistry and Molecular Biology. All rights reserved.

Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson’s disease (PD). As such, functions and dysfunctions of LRRK2 in PD have been the subject of extensive investigation. In addition to PD, increasing evidence is suggesting that LRRK2 is associated with a wide range of diseases. Genome-wide association studies have implicated LRRK2 in Crohn’s disease (CD) and leprosy, and the carriers with pathogenic mutations of LRRK2 show increased risk to develop particular types of cancer. LRRK2 mutations are rarely found in Alzheimer’s disease (AD), but LRRK2 might play a part in tauopathies. The association of LRRK2 with the pathogenesis of apparently unrelated diseases remains enigmatic, but it might be related to the yet unknown diverse functions of LRRK2. Here, we reviewed current knowledge on the link between LRRK2 and several diseases, including PD, AD, CD, leprosy, and cancer, and discussed the possibility of targeting LRRK2 in such diseases.
Keywords: Leucine rich repeat kinase 2 (LRRK2), Parkinson's disease (PD), Alzheimer's disease (AD), Crohn's disease(CD)

This Article